Log in
Enquire now
Stimunity

Stimunity

Research company focused on developing cancer treatments with STING agonists.

OverviewStructured DataIssuesContributors

Contents

stimunity.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Health technology
Health technology
‌
Deep Tech
Technology
Technology
Healthcare
Healthcare
Biotechnology
Biotechnology
Biology
Biology
...
Location
Paris
Paris
France
France
B2X
B2C
B2C
CEO
Sylvain Carlioz
Sylvain Carlioz
Founder
Nicolas Manel
Nicolas Manel
Sylvain Carlioz
Sylvain Carlioz
Pitchbook URL
pitchbook.com/profiles...226321-48
Date Incorporated
2016
Number of Employees (Ranges)
1 – 10
Email Address
contact@stimunity.com
Full Address
24, Rue du Faubourg Saint Jacques 75014 Paris France
Investors
Portage Pharmaceuticals
Portage Pharmaceuticals
Total Funding Amount (USD)
4,200,000
Latest Funding Round Date
2020
Also Known As
Stimunity SAS
Latest Funding Type
Seed
Seed
Country
France
France
Headquarters
Paris
Paris

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
1,080,000

Stimunity specializes in the development of best-in-class drugs on the STING pathway to activate the innate immune system. The company's drugs stimulate patients' immune system to fight back infectious pathogens or cancer.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Stimunity

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.